1. Home
  2. SMMT vs BIP Comparison

SMMT vs BIP Comparison

Compare SMMT & BIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMMT
  • BIP
  • Stock Information
  • Founded
  • SMMT 2003
  • BIP 2007
  • Country
  • SMMT United States
  • BIP Bermuda
  • Employees
  • SMMT N/A
  • BIP N/A
  • Industry
  • SMMT Biotechnology: Pharmaceutical Preparations
  • BIP Marine Transportation
  • Sector
  • SMMT Health Care
  • BIP Consumer Discretionary
  • Exchange
  • SMMT Nasdaq
  • BIP Nasdaq
  • Market Cap
  • SMMT 14.5B
  • BIP 15.7B
  • IPO Year
  • SMMT N/A
  • BIP 2008
  • Fundamental
  • Price
  • SMMT $18.31
  • BIP $34.19
  • Analyst Decision
  • SMMT Strong Buy
  • BIP Strong Buy
  • Analyst Count
  • SMMT 4
  • BIP 2
  • Target Price
  • SMMT $34.75
  • BIP $37.50
  • AVG Volume (30 Days)
  • SMMT 2.1M
  • BIP 356.2K
  • Earning Date
  • SMMT 10-30-2024
  • BIP 11-06-2024
  • Dividend Yield
  • SMMT N/A
  • BIP 4.74%
  • EPS Growth
  • SMMT N/A
  • BIP N/A
  • EPS
  • SMMT N/A
  • BIP N/A
  • Revenue
  • SMMT N/A
  • BIP $20,565,000,000.00
  • Revenue This Year
  • SMMT N/A
  • BIP N/A
  • Revenue Next Year
  • SMMT N/A
  • BIP N/A
  • P/E Ratio
  • SMMT N/A
  • BIP N/A
  • Revenue Growth
  • SMMT N/A
  • BIP 23.37
  • 52 Week Low
  • SMMT $1.88
  • BIP $24.84
  • 52 Week High
  • SMMT $33.89
  • BIP $36.50
  • Technical
  • Relative Strength Index (RSI)
  • SMMT 41.16
  • BIP 46.70
  • Support Level
  • SMMT $19.01
  • BIP $33.79
  • Resistance Level
  • SMMT $22.53
  • BIP $34.88
  • Average True Range (ATR)
  • SMMT 1.45
  • BIP 0.83
  • MACD
  • SMMT -0.21
  • BIP -0.11
  • Stochastic Oscillator
  • SMMT 4.85
  • BIP 31.31

About SMMT Summit Therapeutics Inc.

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

About BIP Brookfield Infrastructure Partners LP

Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from Canada and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.

Share on Social Networks: